On March 25^{th, California regulators delayed the electronic tracking of prescription drugs for two years. The California State Board of Pharmacy voted 12-0 to allow prescription drug manufacturers, distributors and pharmacies an additional two years to begin electronically tracking prescription drugs from the manufacturer to the patient.The requirement was already delayed by the California State Legislation in 2007. Now, the pharmaceutical industry has until January 1, 2011. The delay is intended to allow the pharmaceutical industry time to set up computer systems that would comply with the first ever requirement to track prescriptions.}

The requirement was instituted in California after a recall of fake Lipitor.

There are defective drug attorneys currently working on cases that involve the serious and fatal illnesses that result from defective drugs.

This entry was posted on Wednesday, April 2nd, 2008 at 3:59 am and is filed under Medical Device, Medication, Narcotic, Opioid, Overdose, Pain Management, Pain Reflief, Recall, Safety. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.